The TCAs aren't so bad really if the dose isn't too high, the biggest issue is that they can be used for suicide in high doses which is a serious clinical concern with the population for whom they are designed. In general I think they are a bit more effective than the SSRIs, though the latter seem to be better for certain anxious depressions. They are especially effective in classic melancholic 'endogenous' depression.
The only tetracyclic available that I know of is mirtazapine, which is a kind of interesting drug with its own unique mechanism. It blocks some 5ht receptors kind of like a neuroleptic does, and also is a pretty potent antihistamine, one of the most potent mg per mg. It doesn't inhibit the reuptake of any of the monoamines, but it has indirect effects by blocking autoreceptors, and I believe it is more often prescribed as an add-on to another antidepressant even though it holds its own as a monotherapy in studies. It is kind of sedating esp at lower doses where the antihistamine effects are much larger than the adrenergic, and it makes people hungry, so it is great in cases where weight gain is desired, not so good when it isn't. It is closely related to mianserin, another tetracyclic that I don't believe is available any longer.
Some drugs that aren't classed as TCAs are structurally tricyclic -- the antipsychotic quetiapine is a good example. Tianeptine is another, a really interesting antidepressant that has a poorly understood mechanism of action but seems to enhance the reuptake of serotonin. It produces short-lived pleasant mild stimulation that is anxiolytic. It isn't available from US pharmacies though it is incredibly popular in France. The only real drawback to it is that it has a super short halflife and has to be dosed 3 times per day. I have no idea why they don't make an extended release variation.
The MAOIs are a good choice in certain kinds of depression. The dietary restrictions aren't really that big of a deal unless you really love cheese. And as Sekio said the newer ones don't have the same restrictions (though I don't know as much about their efficacy vs. the older ones -- phenelzine and tranylcypromine)